Northwire Canada EditionTuesday, August 11, 2026
Northwire
TGOL 0.145 +16.0% DEC 0.085 +0.0% NWST 0.290 +1.8% CDA 0.810 −4.7% AVL 5.02 −0.6% FSY 0.585 +2.6% GTC 0.820 +15.5% FCI 0.480 +9.1% IDEX 0.365 +5.8% MERG 0.860 +3.6% CNL 20.03 +1.3% ALGR 0.650 +0.0% MEK 0.055 +10.0% LEGY 0.990 +0.0% RBZ 0.265 −10.2% WAM 0.690 +6.2% TGOL 0.145 +16.0% DEC 0.085 +0.0% NWST 0.290 +1.8% CDA 0.810 −4.7% AVL 5.02 −0.6% FSY 0.585 +2.6% GTC 0.820 +15.5% FCI 0.480 +9.1% IDEX 0.365 +5.8% MERG 0.860 +3.6% CNL 20.03 +1.3% ALGR 0.650 +0.0% MEK 0.055 +10.0% LEGY 0.990 +0.0% RBZ 0.265 −10.2% WAM 0.690 +6.2%
Financings

First Phosphate closes $1.39M tranche of financing

PHOS · Price

Executive Summary

  • First Phosphate Corp. closed a subsequent tranche of its non-brokered private placement, raising $1,390,699 in this specific tranche.
  • In aggregate, the company has raised $3,570,848 across two tranches via the issuance of flow-through shares and hard-dollar units.
  • The company also granted 4.7 million incentive stock options and 1,303,000 Restricted Stock Units (RSUs) to officers, directors, and eligible participants.

Key Details

  • Financing Structure (Current Tranche):
    • Raised $1,390,699 total.
    • Issued 1,111,110 flow-through shares for $999,999.
    • Issued 431,111 hard-dollar units (comprising 431,111 common shares and 431,111 warrants) for $390,700.
    • Paid a corporate finance fee of $12,500.
  • Financing Structure (Aggregate/Both Tranches):
    • Total Gross Proceeds: $3,570,848.
    • Total Flow-Through Shares Issued: 3,355,832 (Gross Proceeds: $3,020,249).
    • Total Hard-Dollar Units Issued: 611,777 (Gross Proceeds: $550,560).
  • Equity Grants:
    • Granted 4.7 million incentive stock options.
    • Granted 1,303,000 Restricted Stock Units (RSUs).
    • Options have an exercise price of $0.90 and expire on Dec. 29, 2028.
    • Options vest 25% every six months for two years following the grant date.
    • RSUs vest on Jan. 1, 2026.
  • Additional Securities:
    • Issued 88,888 compensation common shares at a deemed price of $0.90 per share.
    • Issued 88,888 compensation warrants exercisable at $1.25 per share, expiring April 30, 2026 (subject to accelerated expiry).
  • Regulatory/Other:
    • All securities issued are subject to a four-month-and-one-day statutory hold period.
    • The company has raised approximately $43.6 million in 10 management-led non-brokered private-placement financings since June 2022.
    • The company may close another tranche of the offering at its discretion.
    • Proceeds to be used as disclosed in the Nov. 7, 2025 press release.
Read the original news release →

More from First Phosphate Corp